Cost-effectiveness of the fixed-dose combination tiotropium/olodaterol versus tiotropium monotherapy or a fixed-dose combination of long-acting β2-agonist/inhaled corticosteroid for COPD in Finland, Sweden and the Netherlands: a model-based study

OBJECTIVES: Chronic obstructive pulmonary disease (COPD) guidelines advocate treatment with combinations of long-acting bronchodilators for patients with COPD who have persistent symptoms or continue to have exacerbations while using a single bronchodilator. This study assessed the cost-utility of t...

Descripción completa

Detalles Bibliográficos
Autores principales: Hoogendoorn, Martine, Corro Ramos, Isaac, Soulard, Stéphane, Cook, Jennifer, Soini, Erkki, Paulsson, Emma, Rutten-van Mölken, Maureen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Health Economics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8340281/
https://www.ncbi.nlm.nih.gov/pubmed/34348953
http://dx.doi.org/10.1136/bmjopen-2021-049675

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8340281/
https://www.ncbi.nlm.nih.gov/pubmed/34348953
http://dx.doi.org/10.1136/bmjopen-2021-049675

Ejemplares similares